Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin converting enzyme inhibitors and renal function.

A Mimran1, J Ribstein

  • 1Department of Medicine, Centre Hospitalier Universitaire, Montpellier, France.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|September 1, 1989
PubMed
Summary

Angiotensin converting enzyme (ACE) inhibitors can cause acute kidney injury in specific conditions, particularly when kidney function relies heavily on angiotensin. This risk is heightened by sodium depletion and resolves upon discontinuing the medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Confidence vanished or impaired until distrust in the doctor-patient relationship because of COVID-19: Confidence vanished or impaired until distrust: "COVID" in relationship.

La Revue de medecine interne·2020
Same author

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

The Journal of frailty & aging·2016
Same author

[Appropriate medication prescribing in older people].

La Revue de medecine interne·2015
Same author

[Left ventricular function in hypertension without left ventricular hypertrophy: echographic study with modelisation of left ventricular-aortic coupling].

Annales de cardiologie et d'angeiologie·2014
Same author

[Renin-producing tumor: a rare case of curable hypertension. A case report].

Journal de radiologie·2011
Same author

Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).

Journal of human hypertension·2010

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Angiotensin converting enzyme (ACE) inhibitors are widely used for hypertension management.
  • Angiotensin plays a critical role in regulating glomerular filtration rate (GFR).
  • Certain conditions, including volume depletion and renal artery stenosis, make GFR highly dependent on angiotensin.

Purpose of the Study:

  • To examine the risk of acute renal deterioration associated with ACE inhibitors in specific clinical scenarios.
  • To understand the factors influencing ACE inhibitor-induced acute renal failure.
  • To evaluate the potential of ACE inhibitors in managing chronic kidney disease progression.

Main Methods:

  • Review of clinical conditions where angiotensin is crucial for GFR regulation.

Related Experiment Videos

  • Analysis of factors contributing to ACE inhibitor-induced acute renal failure.
  • Assessment of existing data on ACE inhibitors in chronic parenchymal renal disease and diabetic nephropathy.

    • Main Results:

    • Acute renal deterioration can occur with ACE inhibitors in conditions of high angiotensin dependency for GFR.
    • ACE inhibitor-induced acute renal failure may occur without a drop in systemic blood pressure.
    • Prior sodium depletion enhances the risk, and the condition is reversible upon treatment withdrawal.
    • Promising results exist for ACE inhibitors in diabetic nephropathy, but superiority in chronic parenchymal renal disease needs further demonstration.

    Conclusions:

    • ACE inhibitors pose a risk of acute kidney injury in specific settings of renal compromise.
    • Careful patient selection and monitoring are essential when initiating ACE inhibitors.
    • Further research is needed to confirm the long-term benefits of ACE inhibitors in chronic kidney disease.